Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Env. Regulatory News (SYM)

Share Price Information for Symphony Env. (SYM)

Share Price is delayed by 15 minutes
Get Live Data
6.75    0.00 (0.00%)
Bid:
6.00
Ask:
7.50
Spread: 1.50 (25.00%)
Market Cap: £15.95m
SYM Live PriceLast checked at - London Stock Exchange

Intraday Symphony Env. Share Chart

Pre-Close Trading Update

28 Apr 2026 07:00

RNS Number : 1040C
Symphony Environmental Tech. PLC
28 April 2026
 

 

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

28 April 2026

 

Symphony Environmental Technologies plc

("Symphony", the "Company" or the "Group")

FY-2025 pre-close trading update and

 

Strong start to FY-2026 - first half profitability

 

Symphony Environmental Technologies plc ("Symphony" or the "Group"); global specialists in technologies that make plastic and rubber products "smarter, safer and sustainable", is pleased to provide the following pre-close trading update for the year ended 31 December 2025 ("FY-2025") and notice of FY-2025 results, together with a trading update for the current year to date.

FY2025 trading update (subject to audit)

Further to the Company's announcement on 17 December 2025, the Board now expects that, as a result of management‑driven strategic change in its Middle East operations, Group revenue for FY-2025 will be higher than previously guided, at approximately £5.7 million, with an adjusted loss before interest, tax, depreciation and amortisation ("adjusted LBITDA") broadly comparable to that incurred in the prior year, at approximately £0.9 million.

Importantly, and as further set out below, sales momentum has not just continued but accelerated during the first four months of FY-2026, running at more than 10 per cent. ahead of the same period last year. Furthermore, margins are also improving due to operational leverage as well as the positive impact of strategic initiatives taken during FY-2025, in particular in the Middle East.

In addition to the above adjusted LBITDA, the following one-off costs were incurred during FY-2025 as well as certain asset provisions will be made to the FY-2025 results:

· Strategic costs of £500,000 primarily in relation to the Middle East but also of certain future corporate initiatives;

· Impairment provision of £468,000 against development costs for the Group's antimicrobial products due to extended South American customer trials and commercial evaluation; and

· Other investment provisions of £107,000.

 

 

The net loss including provisions and strategic costs for FY-2025 is expected to be £2.5 million (FY-2024: £1.3 million).

The Board expects to announce its preliminary results for FY-2025 during the latter half of May.

Outlook

The Board remains focused on margin quality, disciplined cost control and the commercialisation of higher‑value technologies, rather than short‑term volume growth.

That said, it is particularly pleasing that trading in the first four months of 2026 has improved materially. The Group delivered a positive EBITDA in Q1-2026, compared with a loss in the corresponding prior‑year and based on current order patterns, expects to deliver a net profit for H1-2026.

Revenues are currently tracking more than 10 per cent ahead of the same period last year. Confirmed orders have been received across all principal markets, particularly Central America. While the timing of shipments remains subject to customer scheduling and customary operational factors, the Board is encouraged by the visibility and quality of the pipeline now in place, which underpins its confidence in the Group's earnings trajectory.

The Group continues to monitor the evolving geopolitical situation in the Middle East, which to date has not had a material adverse effect on operations.

Enquiries:

Symphony Environmental Technologies Plc

Michael Laurier, CEO

Tel: +44 (0) 20 8207 5900

Ian Bristow, CFO

www.symphonyenvironmental.com

Zeus (Nominated Adviser and Broker)

David Foreman, Emma Burn (Investment Banking)

Tel: +44 (0) 203 829 5000

NOTES TO EDITORS

 

 

About Symphony Environmental

 

 

Symphony's d2w masterbatch technology is added to polyethylene (PE) and polypropylene (PP) products at the manufacturing stage at little or no extra cost, and ensures that if they get into the environment at the end of their useful life they will not create microplastics and lie or float around for decades. https://www.symphonyenvironmental.com/technologies/biodegradable-plastic/ Instead they will safely biodegrade, leaving no microplastics or toxicity.

 

If they get collected during their programmed life they can be recycled with ordinary PE and PP without separation See https://www.biodeg.org/subjects-of-interest/recycling-2/

 

Symphony also supplies a range of plastic technologies under its d2p (designed to protect) brand www.d2p.net to provide protection against insects, viruses, bacteria, fungi, rodents, odours, and fire. 

 

It has also introduced a new product under its NbR brand https://www.symphonyenvironmental.com/natural-biodegradable-resin/ to reduce the amount of fossil-derived material in plastic products.

 

Symphony has a diverse and growing customer-base and has established itself as an international business with over 70 distributors around the world. Products made with Symphony's plastic technologies are now available in nearly 100 countries and in many different product applications. Symphony itself is certified according to ISO9001 and ISO14001.

 

Symphony participates in the Committee work of the British Standards Institute (BSI), the American Standards Organisation (ASTM), the European Standards Organisation (CEN), and the International Standards Organisation (ISO).

 

Further information on the Group can be found at www.symphonyenvironmental.com and twitter @SymphonyEnv

 

See also Symphony on Instagram and Linkedin.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVDSAIDFIR
Date   Source Headline
25th Mar 20243:02 pmRNSReplacement - Subscription and Notice of GM
22nd Mar 20247:01 amRNSPrimaryBid Offer
22nd Mar 20247:00 amRNSSubscription, PrimaryBid Offer and Notice of GM
14th Mar 20247:00 amRNSExtension to Convertible Loan Agreements
13th Mar 20247:00 amRNSUS Environmental Protection Agency positive report
9th Feb 20247:59 amRNSEU Judgment – Company Response
31st Jan 20249:48 amRNSEU Court Judgement
18th Jan 20247:00 amRNSTrading Update and EU Case
8th Jan 20247:00 amRNSGrant of options and PDMR dealing
2nd Jan 20247:00 amRNSDirector appointment & grant of options
28th Dec 20237:00 amRNSOptions amendments
18th Oct 20232:10 pmRNS£1.0m convertible loan agreement
29th Sep 20237:00 amRNSInterim Results
26th Sep 20237:00 amRNSYemen Enforces Oxo-Biodegradable Plastic Law
11th Aug 20237:00 amRNSDirectorate Change
1st Aug 20237:00 amRNSPre-close Trading Update
4th Jul 20237:00 amRNSDirectorate Change
29th Jun 20231:46 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM Statement
7th Jun 20238:34 amRNSPosting of Annual Report & Accounts & AGM Notice
30th May 20237:00 amRNSPreliminary Results
21st Mar 20237:00 amRNSEU court hearing
13th Mar 20233:40 pmRNSConvertible loan agreement & revenue update
9th Mar 20237:00 amRNSd2w BioBottles supply agreement with TricorBraun
23rd Dec 20227:00 amRNSTrading update
31st Oct 20227:00 amRNSAttendance at world’s leading plastics trade fair
28th Oct 20222:51 pmRNSDirector/PDMR Shareholdings – Option amendments
29th Sep 20229:00 amRNSInvestor Presentation
29th Sep 20227:01 amRNSSymphony India operations update
29th Sep 20227:00 amRNSInterim results for the 6 m/e 30 June 2022
9th Aug 20227:00 amRNSMexican Technical Standard Validating d2w
8th Aug 20227:00 amRNSAgreement for Middle East manufacturing
1st Aug 20227:01 amRNSEquity subscription and grant of warrants
1st Aug 20227:00 amRNSTrading Update
7th Jul 20227:00 amRNSd2p Anti-Insect Sales
29th Jun 20222:00 pmRNSResult of AGM
29th Jun 20227:00 amRNSAGM Statement
28th Jun 20227:00 amRNSd2p Supply Agreement with Grupo Bimbo
27th Jun 20227:00 amRNSPeru legal action outcome
7th Jun 20227:00 amRNSPosting of Annual Report and Notice of AGM
18th May 20227:00 amRNSAppointment of Executive Director
4th May 20227:00 amRNSGrant of Options
20th Apr 20227:00 amRNSSymphony India Sustainability Award
30th Mar 20227:00 amRNSPreliminary results
24th Feb 20223:49 pmRNSExtension of options
23rd Feb 20227:00 amRNSNew US Supply Contract
17th Dec 20212:09 pmRNSTrading and business update
29th Nov 20217:00 amRNSPositive DEFRA consultation
19th Nov 20212:54 pmRNSDirector/PDMR Shareholding - options amendment
19th Nov 20212:11 pmRNSDirector/PDMR Shareholding - option amendments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.